Specialty Pharmaceuticals

Specialty Pharmaceuticals


Global Specialty Pharmaceuticals Market to Reach US$920.0 Billion by 2030

The global market for Specialty Pharmaceuticals estimated at US$440.7 Billion in the year 2023, is expected to reach US$920.0 Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$396.3 Billion by the end of the analysis period. Growth in the Multiple Sclerosis Therapeutic Area segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$120.1 Billion While China is Forecast to Grow at 15.3% CAGR

The Specialty Pharmaceuticals market in the U.S. is estimated at US$120.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$201.1 Billion by the year 2030 trailing a CAGR of 15.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.1% and 9.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR.

Global Specialty Pharmaceuticals Market - Key Trends and Drivers Summarized

How Are Specialty Pharmaceuticals Revolutionizing Healthcare and Treatment?

Specialty pharmaceuticals are revolutionizing healthcare and treatment by offering targeted, high-efficacy medications for complex and chronic conditions that were previously difficult to manage. These drugs are typically used to treat conditions such as cancer, autoimmune disorders, rare genetic diseases, and HIV, among others. Unlike traditional pharmaceuticals, specialty drugs often involve complex manufacturing processes, require special handling, and are usually administered through injection or infusion, though oral forms also exist. Their development and use are driven by advancements in biotechnology and personalized medicine, which allow for more precise targeting of diseases at the molecular level. The impact of specialty pharmaceuticals is profound, as they not only improve patient outcomes by providing more effective treatments but also offer hope for conditions that had limited or no treatment options in the past. This shift towards specialized care is enhancing the overall quality of healthcare, enabling more personalized and effective treatment regimens.

What Innovations Are Enhancing the Functionality of Specialty Pharmaceuticals?

Innovations in specialty pharmaceuticals are enhancing their functionality through advancements in drug delivery systems, personalized medicine, and the development of biosimilars. One of the key innovations is the improvement in drug delivery methods, such as the use of nanoparticles, liposomes, and other carrier systems that enhance the bioavailability and targeting of drugs to specific cells or tissues, reducing side effects and improving therapeutic outcomes. Personalized medicine, driven by advances in genomics and biomarkers, is allowing for the customization of treatments based on a patient’s genetic makeup, ensuring that specialty pharmaceuticals are more effective for individual patients. Additionally, the development of biosimilars—biologically similar versions of original specialty drugs—offers a more cost-effective alternative while maintaining similar efficacy and safety profiles. This not only increases access to life-saving treatments but also drives competition in the market, potentially reducing the overall cost of specialty medications. These innovations are making specialty pharmaceuticals more accessible, effective, and tailored to the needs of individual patients, thereby transforming the landscape of modern healthcare.

How Do Specialty Pharmaceuticals Impact Patient Outcomes and Healthcare Costs?

Specialty pharmaceuticals have a significant impact on patient outcomes by providing treatments that are often more effective and tailored to the specific needs of individuals with complex conditions. These drugs can dramatically improve quality of life, manage symptoms more effectively, and, in some cases, offer a potential cure for previously untreatable diseases. For patients with chronic conditions, specialty pharmaceuticals can reduce the frequency and severity of disease flare-ups, lower hospitalization rates, and decrease the overall burden of illness. However, the high cost of specialty pharmaceuticals is a double-edged sword, as these medications can be prohibitively expensive, leading to significant challenges for patients and healthcare systems. While the long-term benefits of these drugs can reduce other healthcare costs, such as hospitalizations and surgeries, the initial outlay for treatment can be substantial. This has led to ongoing debates about pricing, insurance coverage, and the sustainability of healthcare systems in providing these advanced treatments. Despite the costs, the profound impact on patient outcomes makes specialty pharmaceuticals a crucial component of modern healthcare, driving ongoing efforts to balance access with affordability.

What Trends Are Driving Growth in the Specialty Pharmaceuticals Market?

Several trends are driving growth in the specialty pharmaceuticals market, including the increasing prevalence of chronic and rare diseases, advancements in biotechnology, and the rise of personalized medicine. As the global population ages and the incidence of chronic conditions like cancer, diabetes, and autoimmune diseases rises, the demand for targeted, effective treatments is growing. Advancements in biotechnology are also fueling the development of new specialty drugs that can address these conditions more precisely and with fewer side effects. The shift towards personalized medicine is another significant driver, as it emphasizes the development of therapies tailored to the individual patient, often leading to better outcomes and more efficient use of resources. Additionally, the emergence of orphan drugs—specialty pharmaceuticals designed to treat rare diseases—has opened new markets and driven significant investment in research and development. Regulatory incentives and the potential for high returns on investment are encouraging pharmaceutical companies to continue exploring this field. These trends underscore the expanding role of specialty pharmaceuticals in addressing unmet medical needs, offering hope for patients with complex and rare conditions, and driving the future of healthcare innovation.

Select Competitors (Total 51 Featured) -
  • Cigna Healthcare
  • CVS Health Corporation
  • Datex Corporation
  • Endo International Plc
  • F. Hoffmann La Roche Ltd.
  • Gilead Sciences Inc.
  • Humana Inc.
  • Hyphens Pharma International Limited
  • Hyphens Pharma Pte Ltd.
  • Kroger Specialty Pharmacy
  • McKesson Corporation
  • Merck Animal Health
  • SERB S.à.r.l.
  • STADA Arzneimittel AG
  • Terso Solutions, Inc.;
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Specialty Pharmaceuticals – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rapid Growth in Biologics Driving the Expansion of the Specialty Pharmaceuticals Market
Advancements in Targeted Therapies Offering New Treatment Avenues
Increased Prevalence of Chronic Diseases Fueling Demand for Specialty Medications
Regulatory Incentives Promoting Orphan Drug Development and Approvals
Expansion of Personalized Medicine and Its Influence on Specialty Pharma
Market Dynamics Shaped by Patent Expiries and the Emergence of Biosimilars
Insurance Coverage and Reimbursement Challenges Affecting Patient Access
Future Trends in Genomics and Gene Therapy Impacting Specialty Pharmaceuticals
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Specialty Pharmaceuticals Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Specialty Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Inflammatory Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Inflammatory Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Inflammatory Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Offline Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Offline Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Offline Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 29: USA Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
CANADA
TABLE 32: Canada Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 35: Canada Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
JAPAN
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 38: Japan Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 41: Japan Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
CHINA
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 44: China Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 47: China Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
EUROPE
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 50: Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Specialty Pharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
FRANCE
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 59: France Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 62: France Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
GERMANY
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 65: Germany Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 68: Germany Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
ITALY
TABLE 71: Italy Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 74: Italy Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
UNITED KINGDOM
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 77: UK Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 80: UK Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
SPAIN
TABLE 83: Spain Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Spain Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Spain 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 86: Spain Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Spain Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Spain 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
RUSSIA
TABLE 89: Russia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Russia Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Russia 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 92: Russia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Russia Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Russia 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of Europe Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of Europe 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of Europe 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Specialty Pharmaceuticals by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
AUSTRALIA
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 110: Australia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Australia Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Australia 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 113: Australia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Australia Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Australia 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
INDIA
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 116: India Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: India Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: India 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 119: India Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: India Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: India 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 122: South Korea Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: South Korea Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: South Korea 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 125: South Korea Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: South Korea Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: South Korea 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Asia-Pacific Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Asia-Pacific Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
LATIN AMERICA
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 134: Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 135: Latin America Historic Review for Specialty Pharmaceuticals by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Latin America 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 137: Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 140: Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Latin America Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Latin America 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 143: Argentina Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Argentina Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Argentina 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 146: Argentina Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Argentina Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Argentina 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
BRAZIL
TABLE 149: Brazil Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Brazil Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Brazil 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 152: Brazil Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Brazil Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Brazil 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
MEXICO
TABLE 155: Mexico Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Mexico Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Mexico 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 158: Mexico Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Mexico Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Mexico 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Rest of Latin America Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Rest of Latin America 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Rest of Latin America Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Rest of Latin America 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
MIDDLE EAST
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 167: Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 168: Middle East Historic Review for Specialty Pharmaceuticals by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Middle East 16-Year Perspective for Specialty Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 170: Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 173: Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Middle East Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Middle East 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
IRAN
TABLE 176: Iran Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Iran Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Iran 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 179: Iran Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Iran Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Iran 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
ISRAEL
TABLE 182: Israel Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Israel Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Israel 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 185: Israel Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Israel Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Israel 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Saudi Arabia Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Saudi Arabia 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Saudi Arabia Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Saudi Arabia 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 194: UAE Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: UAE Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: UAE 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 197: UAE Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: UAE Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: UAE 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Middle East Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Middle East 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Rest of Middle East Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Rest of Middle East 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
AFRICA
Specialty Pharmaceuticals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 206: Africa Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Africa Historic Review for Specialty Pharmaceuticals by Therapeutic Area - Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Africa 16-Year Perspective for Specialty Pharmaceuticals by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, Multiple Sclerosis, Inflammatory Conditions, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2024 & 2030
TABLE 209: Africa Recent Past, Current & Future Analysis for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Africa Historic Review for Specialty Pharmaceuticals by Distribution Channel - Offline Distribution Channel and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Africa 16-Year Perspective for Specialty Pharmaceuticals by Distribution Channel - Percentage Breakdown of Value Sales for Offline Distribution Channel and Online Distribution Channel for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings